Yoshiteru Shimoda, Ichiyo Shibahara, Masayuki Kanamori, Ken-Ichiro Matsuda, Ryuta Saito, Atsushi Hozawa, Toshihiro Kumabe, Hidenori Endo, Teiji Tominaga, Yukihiko Sonoda. Clinical effect of ventricular entry during resection of IDH-wildtype glioblastoma: A multi-institutional analysis. World neurosurgery. 2025. 123643-123643
Masayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, Yukinori Akiyama, Takaaki Beppu, Shigeo Ohba, Toshiyuki Enomoto, Takahiro Ono, Yuta Mitobe, Mitsuto Hanihara, et al. Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection. International journal of clinical oncology. 2025. 30. 1. 51-61
Yoshiteru Shimoda, Masayuki Kanamori, Shota Yamashita, Ichiyo Shibahara, Rei Umezawa, Shunji Mugikura, Keiichi Jingu, Ryuta Saito, Yukihiko Sonoda, Toshihiro Kumabe, et al. Residual Pattern of the Hyperintense Area on T2-Weighted Magnetic Resonance Imaging After Initial Treatment Predicts the Pattern and Location of Recurrence in Patients with Newly Diagnosed Glioblastoma. World neurosurgery. 2024. 193. 517-532
Masayuki Kanamori, Shunji Mugikura, Osamu Iizuka, Naoko Mori, Yoshiteru Shimoda, Ichiyo Shibahara, Rei Umezawa, Keiichi Jingu, Ryuta Saito, Yukihiko Sonoda, et al. Clinical significance of cerebral microbleeds in patients with germinoma who underwent long-term follow-up. Journal of neuro-oncology. 2024. 170. 1. 173-184